Fierce Pharma

NOVEMBER 10, 2022

AstraZeneca withdraws US COVID vaccine application, shifts focus to antibody treatments. Thu, 11/10/2022 - 09:02.

Vaccines 145

Vaccines 145

STAT

AUGUST 16, 2024

When mpox first began to spread internationally in 2022, affected countries scrambled to buy some of the limited supply of poxvirus vaccines produced in the world. The Danish company Bavarian Nordic, maker of the Jynneos smallpox vaccine, faced the sizable challenge of trying to meet demand with its supply.

Vaccines 144

Vaccines 144

Drug Store News

MAY 11, 2023

Spending on medicines—at net manufacturer prices—reached $429 billion in 2022, growing 5.3% including the continued contribution of COVID-19 vaccines and therapeutics, the report revealed.

Vaccines 98

Vaccines 98

pharmaphorum

MAY 19, 2022

Moderna has joined forces with non-profit organisation IAVI on a third phase 1 trial of its candidate HIV vaccine in Africa, where the burden of the virus is still being keenly felt. There are hopes that its mRNA approach, which proved so effective against COVID-19, could succeed where traditional vaccine technologies have failed in HIV.

Vaccines 145

Vaccines Immunization 145

Fierce Healthcare

NOVEMBER 9, 2022

Experts urge polio vaccination to ward off any major resurgence. Wed, 11/09/2022 - 15:06.

Vaccines 135

Vaccines 135

Fierce Pharma

AUGUST 8, 2024

Following the commercial launch of Bavarian Nordic’s smallpox/mpox vaccine Jynneos earlier this year, the Danish company has locked up yet another supply agreement with the U.S. million to “partly replenish” Jynneos vaccine stocks in response to the 2022 outbreak of mpox, the disease formerly known as monkeypox. government. |

Vaccines 131

Vaccines 131

STAT

MARCH 29, 2024

People in Republican-voting states were more likely to report adverse events after receiving a Covid-19 vaccination than people living in Democratic-leaning states, a new analysis finds, suggesting that how people view their post-vaccine side effects or decide whether to report them may be shaped by their political views.

Vaccines 144

Vaccines 144

Fierce Healthcare

JANUARY 13, 2022

Supreme Court upholds HHS' vaccine requirement for healthcare workers, blocks OSHA's large employer mandate. Thu, 01/13/2022 - 15:37.

Vaccines 137

Vaccines 137

Pharmacy Times

NOVEMBER 16, 2022

In a 2019 survey, middle-aged participants were considerably more apprehensive about getting vaccinated than younger groups, which was not the case in the 2022 survey.

Vaccines 132

Vaccines 132

pharmaphorum

JUNE 21, 2021

It would be easy to forget that back in 2019, BioNTech was an early-stage biotech firmly focused on cancer vaccines, before being catapulted onto the world-stage with its COVID-19 shot. Among the 25-strong group given the vaccine on its own, there was one patient who had a complete remission of tumours that had spread from the original site.

Vaccines 145

Vaccines Immunization 145

Fierce Healthcare

JANUARY 7, 2022

Justices appear likely to narrowly uphold CMS vaccine mandate on hold in half of US. Fri, 01/07/2022 - 15:44.

Vaccines 134

Vaccines 134

European Pharmaceutical Review

DECEMBER 22, 2022

has finalised a strategic partnership with the UK government to establish a state-of-the-art mRNA vaccine research, development, and manufacturing facility in the UK. This milestone follows the agreement in principle between Moderna and the UK Government, announced in June 2022. Moderna, Inc.

Vaccines 131

Vaccines 131

pharmaphorum

DECEMBER 4, 2020

Valneva has said it plans to accelerate research into its Lyme disease vaccine candidate VLA15, bringing forward a trial including children into the first quarter of 2021. Pfizer will pay up to $45 million in development related milestone payments and up to $143 million if the vaccine hits early sales targets.

Vaccines 119

Vaccines Immunization 119

pharmaphorum

FEBRUARY 9, 2022

In this article, Ben Hargreaves looks into the promise of cancer vaccines and how this treatment modality may offer advantages over existing immunotherapies in the oncology sector. One area that is gathering increasing levels of interest is the development of cancer vaccines. A broad front.

Vaccines 134

Vaccines Immunization Compounding Pharmaceutical Companies 134

Pharmaceutical Technology

MARCH 28, 2023

Following on from its Covid-19 vaccine programmes, BioNTech has set its sights on a range of infectious diseases for vaccine development. In its FY 2022 report, BioNTech has identified herpes simplex virus (HSV), malaria, and shingles as disease targets. However, following its launch of the world’s first Omicron BA.4/BA.5

Vaccines 110

Vaccines 110

Fierce Healthcare

DECEMBER 19, 2022

COVID-19 vaccines protect against more than just COVID: study. Mon, 12/19/2022 - 12:03.

Vaccines 116

Vaccines 116

STAT

MARCH 4, 2024

Having Covid-19 increases a person’s risk of developing an autoimmune disease in the year after infection, a large study out of South Korea and Japan reports, but vaccination helps decrease that risk. Read the rest…

Vaccines 145

Vaccines Medical Records 145

Fierce Healthcare

JANUARY 18, 2022

CMS sets COVID-19 vaccination deadlines for healthcare workers in 24 more states. Tue, 01/18/2022 - 11:32.

Vaccines 119

Vaccines 119

European Pharmaceutical Review

MAY 9, 2024

Withdrawal of the marketing authorisation for the COVID-19 vaccine (ChAdOx1-S [recombinant]) Vaxzevria (SRD) by the European Medicines Agency on 7 May, follows a request by AstraZeneca. Global demand for all COVID vaccines is now much lower and overall supply exceeds demand.

Vaccines 110

Vaccines 110

Fierce Healthcare

DECEMBER 19, 2022

CDC: Bivalent vaccine cuts risk of COVID hospitalization by half. Mon, 12/19/2022 - 15:28.

Hospitals 111

Hospitals Vaccines 111

Fierce Pharma

DECEMBER 14, 2022

Senators blast Pfizer's proposed COVID vaccine price hike as 'profiteering'. Wed, 12/14/2022 - 09:00. fkansteiner.

Vaccines 111

Vaccines 111

Fierce Pharma

NOVEMBER 23, 2022

On a roll, Takeda's dengue vaccine shifts into FDA's fast review lane. Wed, 11/23/2022 - 09:35.

Vaccines 112

Vaccines FDA 112

European Pharmaceutical Review

AUGUST 2, 2023

A new COVID-19 vaccine has been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA). Bimervax is now the ninth vaccine to be authorised by the UK’s independent medicines regulator to treat the virus. The vaccine demonstrated a strong immune response in the trial.

Vaccines 98

Vaccines Immunization 98

pharmaphorum

SEPTEMBER 15, 2021

The European Commission is reportedly in advanced discussions with French biotech Valneva about picking up the contract to supply COVID-19 vaccines that was terminated by the UK government this week. “Obviously she is not recommending that we administer vaccines that do not get approval,” said Javid.

Vaccines 116

Vaccines 116

pharmaphorum

AUGUST 12, 2021

The UK government has started ordering COVID-19 vaccines for a 2022 booster campaign, including a 32 million-dose order for the Pfizer/BioNTech shot, even before third doses for 2021 have been given the go-ahead. The Johnson & Johnson vaccine is also supplied on a no-profit basis. Pricing slammed.

Vaccines 111

Vaccines Immunization 111

pharmaphorum

JANUARY 19, 2023

Biotech Vaxxas has announced a partnership agreement with the 2017-established Coalition for Epidemic Preparedness Innovations (CEPI), in order to advance the development of Vaxxas’ needle-free vaccine-patch delivery technology with preclinical testing of an mRNA vaccine patch. The agreement, worth $4.3 The agreement, worth $4.3

Vaccines 105

Vaccines Immunization 105

European Pharmaceutical Review

AUGUST 16, 2022

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved an updated version of Moderna’s COVID-19 vaccine, Spikevax, that targets two coronavirus variants as a booster. The regulator confirmed that the vaccine meets its standards of safety, quality and effectiveness. 1) and the original 2020 strain.

Vaccines 105

Vaccines Immunization 105

Pharmaceutical Technology

JULY 1, 2022

Some months after the first Covid-19 vaccines became available, the World Health Organization (WHO) set a target of vaccinating 70% of each country’s population by the end of June 2022. The post Magazine-How delays derailed Covid-19 vaccination in Africa appeared first on Pharmaceutical Technology.

Vaccines 110

Vaccines 110

European Pharmaceutical Review

FEBRUARY 13, 2023

and BioNTech SE have announced the start of a Phase I/II trial for the companies’ mRNA vaccines for shingles (Herpes Zoster), for which there is no currently approved vaccine. Without vaccination, about half of the people who live to age 85 are expected to develop shingles, stated BioNTech. Pfizer Inc.

Vaccines 105

Vaccines 105

Pharmaceutical Technology

JUNE 9, 2023

5+delta) protein vaccine (Sf9 cell). This marks the world’s first Covid-19 vaccine approved for emergency use against XBB descendent lineages of SARS-CoV-2. The vaccine has been developed by WestVac Biopharma along with the West China Medical Center and Sichuan University. recombinant Covid-19 trivalent (XBB.1.5+BA.5+delta)

Vaccines 107

Vaccines 107

STAT

OCTOBER 2, 2023

and Europe are ramping up their campaigns urging eligible people to get another vaccine round against Covid and flu, promoting the immunizations as people’s best way to protect themselves and reduce pressure on health systems during what is expected to be another tough winter. LONDON — Health officials in the U.K.

Vaccines 109

Vaccines Immunization 109

Fierce Pharma

DECEMBER 6, 2022

Pfizer, BioNTech strike back at Moderna with mRNA vaccine patent lawsuit. Tue, 12/06/2022 - 11:27.

Vaccines 100

Vaccines 100

European Pharmaceutical Review

NOVEMBER 3, 2022

GSK has announced the European Medicines Agency (EMA) has validated a marketing authorisation application (MAA) under accelerated assessment for its respiratory syncytial virus (RSV) vaccine for adults above 60. If approved, the vaccine could be the first vaccine to prevent RSV lower respiratory tract disease (LRTD) in older adults.

Vaccines 105

Vaccines 105

Pharmaceutical Technology

DECEMBER 11, 2022

The US Food and Drug Administration (FDA) has granted Fast Track designation for Pfizer and BioNTech’s messenger ribonucleic acid (mRNA)-based combination vaccine candidate against Covid-19 and influenza. The vaccine is intended to prevent two respiratory ailments through a single injection. 5 Omicron sublineages spike proteins.

Vaccines 115

Vaccines FDA Communication 115

Fierce Pharma

NOVEMBER 10, 2022

Sanofi, GSK crash the COVID-19 vaccine party late with a world-first nod for their next-gen booster. Thu, 11/10/2022 - 14:09. fkansteiner.

Vaccines 108

Vaccines 108

pharmaphorum

JUNE 9, 2022

Moderna’s new version of its COVID-19 vaccine, which targets two virus variants including Omicron, has outperformed the company’s original Spikevax shot in a head-to-head clinical trial. It has predicted sales of COVID-19 vaccines will be around $21 billion this year. Three-month data will be reported later this summer.

Vaccines 105

Vaccines FDA 105

European Pharmaceutical Review

DECEMBER 2, 2022

Vaccines Europe has unveiled its first pipeline review of its 15 members companies, with 100 vaccine candidates as of July 2022. . The data indicated 46 percent of the vaccine candidates target infections that do not have an available vaccine. Improve access and convenience to immunisation for adults.

Vaccines 98

Vaccines Immunization 98